HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M200004-MCP200v1 1/5/387    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vejda, S. Articles by Gerner, C. Search for Related Content PubMed PubMed Citation Articles by Vejda, S. Articles by Gerner, C. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 1:387-393, 2002.
© 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Research

Plasma from Cancer Patients Featuring a Characteristic Protein Composition Mediates Protection against Apoptosis^*

Susanne Vejda, Carsten Posovszky, Sieglinde Zelzer^¶, Barbara Peter, Editha Bayer, Dieter Gelbmann, Rolf Schulte-Hermann and Christopher Gerner^,||

Institute of Cancer Research, University of Vienna, 1090 Vienna, Austria
University Children’s Hospital, 89077 Ulm, Germany
^¶ Institute of Molecular Biology, University of Graz, 8010 Graz, Austria

By comparative proteome analysis we searched for characteristic alterations of human plasma accompanying neoplastic disease. We identified protein alterations in plasma of prostate-, lung-, and breast-cancer patients in comparison to controls, comprising elevated levels of fibrinogen -chain dimer, degradation products of antiplasmin and laminin -chain, and elevated levels of acute phase proteins. The latter proteins and laminin fragments have been described as anti-apoptotic factors. We raised the question whether these alterations may have any relevance for the regulation of apoptosis. In contrast to plasma derived from healthy donors, samples from prostate-, lung-, and breast-cancer patients selectively inhibited Fas- and staurosporine-induced apoptosis in Jurkat cells but remained ineffective upon UV light-induced apoptosis. These data suggested that inhibition occurred by extracellular interference with apoptosis induction. Supporting this hypothesis, we found that formation of the CD95 death-inducing signal complex was strongly inhibited in the presence of plasma from cancer patients.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Zhang and D. W. Chan Cancer Biomarker Discovery in Plasma Using a Tissue-targeted Proteomic Approach Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1915 - 1917. [Full Text] [PDF]

				H. Zhang, E. C. Yi, X.-j. Li, P. Mallick, K. S. Kelly-Spratt, C. D. Masselon, D. G. Camp II, R. D. Smith, C. J. Kemp, and R. Aebersold High Throughput Quantitative Analysis of Serum Proteins Using Glycopeptide Capture and Liquid Chromatography Mass Spectrometry Mol. Cell. Proteomics, February 1, 2005; 4(2): 144 - 155. [Abstract] [Full Text] [PDF]

				H. Hondermarck Breast Cancer: When Proteomics Challenges Biological Complexity Mol. Cell. Proteomics, May 1, 2003; 2(5): 281 - 291. [Abstract] [Full Text] [PDF]

				C. Gerner, S. Vejda, D. Gelbmann, E. Bayer, J. Gotzmann, R. Schulte-Hermann, and W. Mikulits Concomitant Determination of Absolute Values of Cellular Protein Amounts, Synthesis Rates, and Turnover Rates by Quantitative Proteome Profiling Mol. Cell. Proteomics, July 1, 2002; 1(7): 528 - 537. [Abstract] [Full Text] [PDF]